Author

Nicole O. Williams

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University

Observed institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University

OpenAlex ID: A5132842833

Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and pain

2026 · Jeremy T. Beales, Varshasnata Mohanty, et al. · Brain Behavior and Immunity · 4

The gut microbiome in chemotherapy-induced fatigue: Exploring clinical associations and modulation via fecal microbiota transplantation in female mice

2026 · Ángela del Águila, Jeremy T. Beales, et al. · International Immunopharmacology

Effect of tango versus exercise on chemotherapy-induced neuropathy after breast cancer treatment: a Phase II randomized controlled trial

2026 · Lise Worthen-Chaudhari, Patrick Schnell, et al. · Research Square

Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2 -Negative Breast Cancer

2026 · Claudine Isaacs, Rita Nanda, et al. · JAMA Oncology

Episodic Future Thinking: A Behavioral Intervention to Promote Weight Loss in Breast Cancer Survivors (Alliance A21-Pilot10)

2026 · Jasmine S. Sukumar, Maryam B. Lustberg, et al. · JCO oncology advances.

Abstract 6645: Practice patterns impacting relative dose intensity of adjuvant capecitabine among triple negative breast cancer patients with residual disease following neoadjuvant chemotherapy.

2026 · Andrea House, Pratik Thakur, et al. · Cancer Research

Abstract 6646: Impact of histology subtypes (ductal, lobular, and mixed ductal/lobular) on pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) and chemoimmunotherapy (NACI) for estrogen receptor low (ER-low) HER2-negative breast cancer.

2026 · Kai C. Johnson, Brandon Slover, et al. · Cancer Research

Chemotherapy-induced estradiol reduction is associated with less relief of pre-chemotherapy anxiety in breast cancer patients

2026 · Ángela del Águila, Lindsay D. Strehle, et al. · Psychoneuroendocrinology

COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium

2026 · Alaina J. Brown, Chih-Yuan Hsu, et al. · JCO oncology advances.

Works count: 9

Citation count: 4

H-index: 1

I10-index: